Investors need to pay close attention to Harmonic (HLIT) stock based on the movements in the options market lately.

Fintel reports that on October 29, 2024, Jefferies downgraded their outlook for Harmonic (NasdaqGS:HLIT) from Buy to Hold.

The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Third Harmonic Bio, Inc. (THRD). While the effectiveness of this highly sought-after metric is ...

If that’s indeed the case, Australian acoustic guitar maestro Tommy Emmanuel certainly has a lot more than that under his belt. One of only five guitarists to be bestowed the title “Certified Guitar ...

Robot actuators must generate high torques, but at the same time be light and compact. The ideal application for the Harmonic ...

THB335 Phase 1 SAD/MAD clinical trial on track to deliver clinical results in 1Q’25 Strong financial position with cash and cash equivalents ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.26% of ...

The Harmonic Drive is a key part of countless robotic applications. Incredibly simple yet quite odd to watch, this gear system is extremely precise with an impressive torque-to-weight ratio, even if ...

Third Harmonic Bio, Inc. ( (THRD) ) has released its Q3 earnings. Here is a breakdown of the information Third Harmonic Bio, Inc. presented to ...

Harmonic Inc. reports strong Q3 results but faces concerns, leading to a cautious outlook. Click for more on HLIT Stock and its most recent earnings release.

Research analysts at Northland Capmk raised their FY2024 earnings per share (EPS) estimates for Harmonic in a report issued ...